Olszowy named CTO at ViroCyt
ViroCyt develops instrumentation and reagents that allow for the quantification of virus particles in a given sample in just minutes.
The company was founded in early 2013 as a spinoff of Boulder-based InDevR Inc., and was originally based in Denver before moving to Boulder in November.
SPONSORED CONTENT
Commercial Solar is a big investment, but not an overwhelming one
Solar offers a significant economic benefit for commercial property owners while also positively impacting the environment and offering a path to compliance for new municipal requirements like Energize Denver. A local, experienced solar installer will help you navigate the complexities of commercial solar to achieve financial success for your project.
Olszowy, who has a doctorate in experimental pathology, comes to ViroCyt from Thermo Fisher Scientific, where he was instrumental in the launch of the Attune acoustic focusing cytometer. At ViroCyt, he will lead the company’s efforts to evolve its Virus Counter technology.
“Dr. Olszowy brings to ViroCyt an outstanding record of development of innovative products in the bioscience field,” ViroCyt chief executive Robert Kline said in a release.
ViroCyt develops instrumentation and reagents that allow for the quantification of virus particles in a given sample in just minutes.
The company was founded in early 2013 as a spinoff of Boulder-based InDevR Inc., and was originally based in Denver before moving to Boulder in November.
Olszowy, who has a doctorate in experimental pathology, comes to ViroCyt from Thermo Fisher Scientific, where he was instrumental in the launch of the Attune acoustic focusing cytometer. At ViroCyt, he will lead the company’s efforts to evolve…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!